Scinai Immunotherapeutics Ltd (SCNI) — Cash Flow-to-Debt Ratio
Scinai Immunotherapeutics Ltd (SCNI) has a Cash Flow-to-Debt Ratio of -0.32x as of June 2025, meaning its operating cash flow of $-1.29 Million could theoretically repay 0% of its total liabilities ($3.98 Million) in one year. See Scinai Immunotherapeutics Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Scinai Immunotherapeutics Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Scinai Immunotherapeutics Ltd across 17 annual periods. Also explore how fast is Scinai Immunotherapeutics Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Scinai Immunotherapeutics Ltd (2006–2024)
Year-by-year debt coverage analysis for Scinai Immunotherapeutics Ltd. For market capitalisation and broader financial context, see how much is Scinai Immunotherapeutics Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.83x | $-6.33 Million | $3.47 Million | ▼ -328.8% |
| 2023 | -0.43x | $-9.38 Million | $22.04 Million | ▼ -68.9% |
| 2022 | -0.25x | $-7.26 Million | $28.83 Million | ▼ -5.4% |
| 2021 | -0.24x | $-7.43 Million | $31.05 Million | ▲ +76.4% |
| 2020 | -1.01x | $-22.57 Million | $22.25 Million | ▼ -138.0% |
| 2019 | -0.43x | $-22.31 Million | $52.36 Million | ▼ -2.1% |
| 2018 | -0.42x | $-15.29 Million | $36.65 Million | ▼ -5.6% |
| 2017 | -0.40x | $-2.89 Million | $7.31 Million | ▲ +81.6% |
| 2016 | -2.15x | $-2.51 Million | $1.17 Million | ▼ -62.4% |
| 2015 | -1.32x | $-2.63 Million | $1.99 Million | ▲ +67.2% |
| 2014 | -4.04x | $-1.94 Million | $481.23K | ▼ -76.4% |
| 2013 | -2.29x | $-1.21 Million | $529.76K | ▲ +65.8% |
| 2012 | -6.69x | $-1.82 Million | $272.58K | ▼ -11.4% |
| 2011 | -6.00x | $-2.71 Million | $450.86K | ▼ -94.4% |
| 2010 | -3.09x | $-2.29 Million | $742.07K | ▼ -85.6% |
| 2009 | -1.66x | $-852.95K | $512.67K | ▼ -4093.0% |
| 2006 | 0.04x | $10.00K | $240.00K | — |